| Product NDC: | 68016-193 |
| Proprietary Name: | Loperamide HCl |
| Non Proprietary Name: | LOPERAMIDE HYDROCHLORIDE |
| Active Ingredient(s): | 2 mg/1 & nbsp; LOPERAMIDE HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, LIQUID FILLED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68016-193 |
| Labeler Name: | Chain Drug Consortium, LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | NDA021855 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121204 |
| Package NDC: | 68016-193-12 |
| Package Description: | 2 BLISTER PACK in 1 BOX (68016-193-12) > 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK |
| NDC Code | 68016-193-12 |
| Proprietary Name | Loperamide HCl |
| Package Description | 2 BLISTER PACK in 1 BOX (68016-193-12) > 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK |
| Product NDC | 68016-193 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | LOPERAMIDE HYDROCHLORIDE |
| Dosage Form Name | CAPSULE, LIQUID FILLED |
| Route Name | ORAL |
| Start Marketing Date | 20121204 |
| Marketing Category Name | NDA |
| Labeler Name | Chain Drug Consortium, LLC |
| Substance Name | LOPERAMIDE HYDROCHLORIDE |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |